Literature DB >> 1310100

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

D Aderka1, H Engelmann, Y Maor, C Brakebusch, D Wallach.   

Abstract

The receptors for tumor necrosis factor (TNF) exist in cell-associated as well as soluble forms, both binding specifically to TNF. Since the soluble forms of TNF receptors (sTNF-Rs) can compete with the cell-associated TNF receptors for TNF, it was suggested that they function as inhibitors of TNF activity; at high concentrations, the sTNF-Rs indeed inhibit TNF effects. However, we report here that in the presence of low concentrations of the sTNF-Rs, effects of TNF whose induction depend on prolonged treatment with this cytokine are augmented, reflecting an attenuation by the sTNF-Rs of spontaneous TNF activity decay. Evidence that this stabilization of TNF activity by the sTNF-Rs follows from stabilization of TNF structure within the complexes that TNF forms with the sTNF-Rs is presented here, suggesting that the sTNF-Rs can affect TNF activity not only by interfering with its binding to cells but also by stabilizing its structure and preserving its activity, thus augmenting some of its effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310100      PMCID: PMC2119112          DOI: 10.1084/jem.175.2.323

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  The active form of tumor necrosis factor is a trimer.

Authors:  R A Smith; C Baglioni
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

Review 2.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Tumor cell killing by freshly isolated peripheral blood monocytes.

Authors:  D G Fischer; W J Hubbard; H S Koren
Journal:  Cell Immunol       Date:  1981-03-01       Impact factor: 4.868

4.  Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.

Authors:  W Digel; M Stefanic; W Schöniger; C Buck; A Raghavachar; N Frickhofen; H Heimpel; F Porzsolt
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

5.  Tumor necrosis factor in middle ear effusions.

Authors:  D Ophir; T Hahn; A Schattner; D Wallach; A Aviel
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-11

6.  Preparations of lymphotoxin induce resistance to their own cytotoxic effect.

Authors:  D Wallach
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Isolation and characterization of a tumor necrosis factor binding protein from urine.

Authors:  I Olsson; M Lantz; E Nilsson; C Peetre; H Thysell; A Grubb; G Adolf
Journal:  Eur J Haematol       Date:  1989-03       Impact factor: 2.997

8.  Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

Authors:  F T Cordingley; A Bianchi; A V Hoffbrand; J E Reittie; H E Heslop; A Vyakarnam; M Turner; A Meager; M K Brenner
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

9.  Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response.

Authors:  S Nelson; G J Bagby; B G Bainton; L A Wilson; J J Thompson; W R Summer
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

10.  Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Authors:  J Vilcek; V J Palombella; D Henriksen-DeStefano; C Swenson; R Feinman; M Hirai; M Tsujimoto
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  169 in total

Review 1.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

2.  The 75-kD tumour necrosis factor (TNF) receptor is specifically up-regulated in monocytes during Q fever endocarditis.

Authors:  E Ghigo; C Capo; N Amirayan; D Raoult; J Mege
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies.

Authors:  Anthony D Dorr; Michael R Wilson; Kenji Wakabayashi; Alicia C Waite; Brijesh V Patel; Nico van Rooijen; Kieran P O'Dea; Masao Takata
Journal:  J Appl Physiol (1985)       Date:  2011-04-21

4.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.

Authors:  S H Kim; M Eisenstein; L Reznikov; G Fantuzzi; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 5.  Metalloproteinases, inflammation, and rheumatoid arthritis.

Authors:  F F Mohammed; D S Smookler; R Khokha
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

6.  Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

Authors:  F Torre; S Rossol; N Pelli; M Basso; A Delfino; A Picciotto
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

7.  Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational Study.

Authors:  Kei-hang K Chan; Kathleen Brennan; Nai-chieh Y You; Xuyang Lu; Yiqing Song; Yi-Hsiang Hsu; Gautum Chaudhuri; Lauren Nathan; Lesley Tinker; Simin Liu
Journal:  Clin Chem       Date:  2010-12-13       Impact factor: 8.327

8.  A radioreceptor assay for TNF alpha-binding proteins.

Authors:  V Miller; K D Muirden
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

9.  Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.

Authors:  O M Howard; K A Clouse; C Smith; R G Goodwin; W L Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.

Authors:  F De Benedetti; M Massa; P Pignatti; S Albani; D Novick; A Martini
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.